Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells

Area of Science:

• Molecular Biology
• Gene Silencing
• Drug Delivery

Background:

• RNA interference (RNAi) utilizes short-interfering RNA (siRNA) to degrade target messenger RNA (mRNA) via the RNA-induced silencing complex (RISC).
• Understanding siRNA localization is critical for optimizing RNAi-based therapeutics and research tools.

Purpose of the Study:

• To investigate the correlation between siRNA delivery methods, cellular localization, and RNA interference (RNAi) efficacy.
• To determine the specific subcellular localization required for effective siRNA-mediated gene silencing.

Main Methods:

• Delivery of siRNA using siRNA-TAT(47-57) peptide, siRNA-TAT(47-57)-derived oligocarbamate conjugates, and nanoparticles.
• Microscopic analysis to track siRNA localization within cells.
• Assessment of RNAi activity based on mRNA degradation.

Main Results:

• A distinct perinuclear localization of siRNA was observed, correlating with successful RNAi.
• siRNA localization remained consistent regardless of sequence variation or target mRNA presence.
• Conjugation of siRNA to TAT(47-57) peptide or oligocarbamate enhanced RNAi activity and maintained perinuclear localization, differing from free peptide nucleolar localization.

Conclusions:

• Perinuclear localization is a key factor for siRNA engagement with RISC and subsequent RNAi.
• siRNA delivery strategies can be optimized by considering their impact on subcellular localization.
• Interactions with RISC appear to be the primary determinant of siRNA localization, even when conjugated to delivery peptides.